SOPHiA GENETICS SA annual stock-based compensation
2019
2020
2021
2022
2023
2024
2025
SOPHiA GENETICS SA Stock-Based Compensation Growth & History (SOPH)
SOPHiA GENETICS SA's stock-based compensation was $93.7M for fiscal 2025.
View full SOPHiA GENETICS SA company overviewSOPHiA GENETICS SA annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $93.7M | $7.5M | +8.72% |
| 2024 | 2024-12-31 | $86.1M | −$4.0M | −4.47% |
| 2023 | 2023-12-31 | $90.2M | $5.8M | +6.82% |
| 2022 | 2022-12-31 | $84.4M | $13.7M | +19.43% |
| 2021 | 2021-12-31 | $70.7M | $25.6M | +56.83% |
| 2020 | 2020-12-31 | $45.1M | $13.6M | +43.34% |
| 2019 | 2019-12-31 | $31.4M | — | — |
SOPHiA GENETICS SA quarterly stock-based compensation
Q2.21
Q2.22
Q2.23
Q2.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.5M | $136,000 | +3.12% |
| Q1 2026 | 2026-03-31 | $3.3M | — | — |
| Q4 2025 | 2025-12-31 | $3.9M | — | — |
| Q3 2025 | 2025-09-30 | $4.1M | — | — |
| Q2 2025 | 2025-06-30 | $4.4M | $273,000 | +6.69% |
| Q2 2024 | 2024-06-30 | $4.1M | −$593,000 | −12.68% |
| Q2 2023 | 2023-06-30 | $4.7M | $787,000 | +20.24% |
| Q2 2022 | 2022-06-30 | $3.9M | — | — |
| Q2 2021 | 2021-07-27 | $300,000 | — | — |
SOPHiA GENETICS SA stock-based compensation trends
Over the last five fiscal years, SOPHiA GENETICS SA's stock-based compensation increased from $45.1M to $93.7M, a change of $48.6M. The latest reported quarter, Q2 2026, shows $4.5M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review SOPHiA GENETICS SA source filings ↗